|
|
|
| Factors Affecting the Impact of |
||
| TTTLTBI |
||
|
|
|
|
|
|
|
| • | Tuberculin skin
testing |
|||||
| • | Prediction of
progression to disease |
|||||
| • | Completion
of therapy and programmatic costs |
|||||
| • | Efficacy
of treatment |
|||||
| • | Safety of
treatment |
|||||